Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model

Transplantation Proceedings

Volumn 32, Issue 5, 2000, Pages 899-900

  Fiane, A E ^a   Videm, V ^b   Lambris, J D ^d   Geiran, O R ^a   Svennevig, J L ^a   Mollnes, T E ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPSTATIN; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; COMPLEMENT ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY PERFUSION; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

ANIMALS; BLOOD TRANSFUSION; COMPLEMENT ACTIVATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034637356     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01028-9     Document Type: Conference Paper

References (4)

1. Fiane A.E., Videm V., Foerster A., et al. J Surg Res. 30:1998;341.
2. Fiane A.E., Videm V., Mellbye O.A., et al. Scand J Immunol. 47:1998;568.
3. Fiane A.E., Mollnes T.E., Videm V., et al. Xenotransplantation. 6:1999;52.
4. Fiane A.E., Videm V., Johansen H.T., et al. Immunopharmacology. 42:1999;231.